Our Methodology

PipelineEvidence is a specialized oncology intelligence platform designed to provide healthcare professionals, researchers, and pharmaceutical industry stakeholders with comprehensive, evidence-based information about FDA-approved cancer therapies. Founded in 2025, our mission is to improve access to accurate prescribing information and support informed treatment decisions in oncology.

Our Global Mission

We believe that access to accurate, comprehensive drug information is essential for optimal cancer care. PipelineEvidence aggregates data from authoritative sources including FDA package inserts, ClinicalTrials.gov, and peer-reviewed medical literature to create a centralized resource for oncology drug intelligence.

Our platform serves medical oncologists, hematologists, oncology pharmacists, clinical researchers, pharmaceutical medical affairs professionals, and healthcare administrators who need quick access to detailed prescribing information, dosing protocols, and clinical trial data.

What We Provide

Comprehensive Drug Profiles

Each drug profile in our database includes:

Complete FDA-Approved Indications: Full indication text without abbreviations, covering all approved uses
Detailed Dosing Schedules: Precise dosing information including loading doses, maintenance doses, and dose modifications
Cycle Length Information: Treatment cycle specifications and scheduling details
Combination Therapy Protocols: Approved combination regimens with partner drugs and dosing schedules
Clinical Trial References: Direct links to pivotal trials on ClinicalTrials.gov
Manufacturer Information: Drug manufacturer and FDA approval dates

Coverage Areas

PipelineEvidence currently covers 10 major tumor types:

Breast Cancer (9 FDA-approved therapies)
Non-Small Cell Lung Cancer (8 FDA-approved therapies)
Multiple Myeloma (10 FDA-approved therapies)
Melanoma (7 FDA-approved therapies)
Prostate Cancer (8 FDA-approved therapies)
Colorectal Cancer (7 FDA-approved therapies)
Renal Cell Carcinoma (9 FDA-approved therapies)
Pancreatic Cancer (3 FDA-approved therapies)
Bladder/Urothelial Cancer (6 FDA-approved therapies)
Ovarian Cancer (5 FDA-approved therapies)

Data Sources and Accuracy

All information on PipelineEvidence is sourced directly from FDA-approved package inserts and ClinicalTrials.gov registry data. We update our database regularly to reflect new approvals, label changes, and emerging clinical trial data. However, users should always consult official FDA labeling and prescribing information for the most current details before making clinical decisions.

Who Uses PipelineEvidence

Healthcare Professionals

Medical oncologists, hematologists, and oncology pharmacists use PipelineEvidence as a quick reference for dosing schedules, approved indications, and combination therapy protocols. Our platform provides the essential prescribing details needed at the point of care.

Clinical Researchers

Researchers use our platform to identify relevant clinical trials, review approved treatment regimens, and access pivotal trial data for literature reviews and study design.

Pharmaceutical Professionals

Medical affairs, medical science liaisons, and commercial teams in the pharmaceutical industry use PipelineEvidence to understand the competitive landscape, review standard of care protocols, and access comprehensive drug information across therapeutic areas.

Our Approach to Evidence-Based Information

PipelineEvidence is committed to presenting only FDA-approved information from authoritative sources. We do not provide medical advice, treatment recommendations, or clinical decision support beyond presenting factual prescribing information. Our goal is to aggregate and present data in an accessible format while maintaining scientific accuracy and regulatory compliance.

Continuous Improvement

We are continuously expanding our database to include additional tumor types, newly approved therapies, and enhanced data fields. Our development roadmap includes:

Expansion to additional solid tumor and hematologic malignancy types
Integration of real-world evidence data and outcomes research
Enhanced search and filtering capabilities
Mobile-optimized interface for point-of-care access
Automated alerts for new drug approvals and label changes

Contact and Feedback

We welcome feedback from healthcare professionals, researchers, and industry stakeholders. If you have suggestions for improving PipelineEvidence or would like to report an error in our database, please visit our contact page.

For advertising and sponsorship opportunities, please email info@pipelineevidence.com.